Long-acting injectable risperidone extends time to relapse

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1638, 2008-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-acting injectable risperidone is more effective than oral risperidone for psychosis

By  

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives

By Möller Hans-Jürgen  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1541-1566

Adis International

Access to resources Recommend Favorite

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

By Bhanji N.H.   Chouinard G.   Margolese H.C.  

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable

By Rosa Fernanda  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 267-279

Adis International

Access to resources Recommend Favorite

Spotlight on Long-Acting Risperidone in Schizophrenia

By Tracy Swainston Harrison   Karen L. Goa  

American Journal of Drug Delivery, Vol. 2, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite